Rojo J, Gutiérrez PJ, Estrada-González G, García-García JJ

Language: Spanish
References: 21
Page: 7-11
PDF size: 77.96 Kb.

ABSTRACT

The plasma is the blood fraction that contains the clotting factors, albumin and immunoglobulins necessary to correct coagulopathies, however, plasma indications are very specific and most of its demands are not justify. In order to know the more frequent not justified indications of plasma in the Hospital General de Mexico; we registered prospectively in a period of three years all the required plasmas at the Blood Bank during the matutine duty. We authorized those requirements justified with abnormal prothrombin coagulation time (PT): ‹ 60% and considering each case solicitude. From 2874 plasma units required on this period, 290 (10 %) had no justification, being the most demanding services: Oncology and Surgery. The most frequent not justified indication was Surgery, followed by “to improve clotting times” (evens with PT › 60%) without evidence of bleeding, thrombocytopenia and hypoalbuminemia. Almost a third of the not justified solicitudes referred normal clotting times and 13% of them did not count with this study. Plasma demands evidences the limited knowledge of its indications and exposes the patients to innecessary risks.

REFERENCES

1. Norma Oficial Mexicana NOM-003-SSA2-1993, para la disposición de sangre y sus componentes con fines terapéuticos.

2. Terapia transfusional de plasma. En: Recomendaciones para la terapia transfusional de sangre y sus componentes. Consenso de Expertos en Medicina transfusional. Mineral del Chico, Hidalgo. 27-29 de febrero y San Juan del Río, Qro. 28-30 de marzo del 2003; 32-35.

3. Bucur SZ, Berkman EM, Hillyer CD. Transfusion of plasma derivatives: fresh-frozen plasma ,cryoprecipitate, albumin and immunoglobulins. In: Hoffmann. Hematology: Basic principles and practice. 3rd ed. New York, NY: Churchill Livingstone, 2000.

4. NIH Consensus Conference: Fresh frozen plasma: indications and risks. JAMA 1985; 253: 551.

5. Mannuci PM, Federeci AB, Sirchia G. Hemostasis testing during massive blood replacement. Vox Sang 1982; 42: 113.

6. Harke H, Rahman S. Haemostatic disorders in massive transfusion. Bibli Haematol 1980; 46: 179.

7. Kruskall MS, Mintz PD, Bergin JJ et al. Transfusion therapy in emergency medicine. Ann Emerg Med 1988; 17: 327.

8. Shearer MJ, Barkhan P. Vitamin K1 and therapy of massive warfarin overdose. Lancet 1979; 1: 266.

9. Colman RW, Robboy SJ, Minna JD. Disseminated intravascular coagulation: A reappraisal. Annu Rev Med 1979; 30: 359.

10. Novitzky N, Jacobs P, Rosenstrauch W. The treatment of thrombotic thrombocytopenic purpura: Plasma infusion or exchange? Br J Haematol 1994;87:317.

11. Egerman RS, Witlin AG, Friedman SA et al. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: Review of 11 cases. Am J Obstet Gynecol 1996; 175: 950.

12. Rock G, Shumak KH, Sutton DMC et al. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Br J Haematol 1996; 94: 383.

13. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DBL, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004; 126: 139-152.

14. Pamphilon DH. Viral inactivation of FFP. Br J Haematol 2000; 109: 680-693.

15. Guidelines for the blood transfusion services in the UK. The red book. 6th ed. London: TSO, 2002.

16. British Committee for Standards in Haematology. BCSH (2004a) The use of fresh frozen plasma, cryoprecipitate and cryosupernatant (updated). Br J Haematol 2004; 10: 1365-2141.

17. British Committee for Standards in Haematology. BCSH (2004b) Transfusion guidelines for neonates and older children. Br J Haematol 2004; 124: 433-453.

18. College of American Pathologists. Fresh–frozen plasma, cryoprecipitate and platelets administration. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate and platelets. Platelets administration practice guidelines development task force of the College of American Pathologists. J Am Med Assoc 1994; 271: 777-781.

19. Practice Guidelines for Blood Component Therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84 (3); 732-747.

20. López-Hernández JC, Lomelí-Guerrero A, López-Pérez P, Best-Aguilera CR. Optimización del uso del plasma fresco congelado a través de educación y vigilancia. XLII Congreso Nacional de Hematología: Medicina Transfusional. Rev Biomed 2001; 12 (supl 1): S59.

21. Yepez-Alfaro I, Pérez-Herrera M, Figueroa-Sandoval F. Uso racional o abuso del plasma fresco congelado en instituciones hospitalarias en la ciudad de Tepatitlán, Jalisco. XLII Congreso Nacional de Hematología: Medicina Transfusional. Rev Biomed 2001; 12 (supl 1): S59-60.